The results indicated that the combination of anti-PD-1 antibody treatment and PES1 knockdown showed more potent suppressive effects on the subcutaneous growth of ESCC cells than either anti-PD-1 antibody treatment or PES1 knockdown alone (Fig. 7A–C). The gene discussed is PDCD1; the disease is esophageal squamous cell carcinoma.